Payton Nyquvest, Founder of Numinus ketamine clinics, joins The Psychedelic Podcast to discuss psychedelic industry missteps, opportunities, & the future of communal healing.
Find episode links, summary, and transcript here.
Embracing disruptions and learning from failures are essential in the trailblazing space of psychedelics.
Encouraging industry resiliency, Payton Nyquvest, Founder, Chair, & CEO of Numinus, joins Paul F. Austin to discuss how to conquer setbacks on the path to revolutionizing mental health. Payton believes successful psychedelic leaders must adapt to real-world needs, embrace challenges, and gain conscious insights from direct experiences. Only then can innovators and practitioners create a lasting impact on the world.
Payton Nyquvest is the Founder, Chair, & Chief Executive Officer of Numinus, which empowers people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based, psychedelic-assisted therapies. He has a deep understanding of the psychedelic industry from its infancy, driven by life-saving personal experiences with multiple modalities.
At Numinus, Payton guides strategy, innovation, research, and expansion. He also supports marketing and capital-markets functions.
Highlights:
- How Numinus aligns psychedelic therapy with real-world needs.
- Numinus’s three-year journey from inception.
- Numinus’s experiential training and intuitive drug development.
- Exploring whether psychedelic therapists need first-hand experience.
- Payton’s take on conscious leadership in psychedelic-informed business models.
- Numinus’s collaboration with East Forest.
- Payton’s vision for Numinus clinics and practitioner training.
Key Links:
Episode Sponsors:
